Pharmaceutical

pharma-news-for-boehringer-ingelheim-novartis-astellas-pfizer

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Boehringer Ingelheim’s Diabetic Macular Ischemia Study; Novartis’ Mariana Oncology Acquisition; Astellas and Poseida Therapeutics Partnership; Prime Medicine’s PM359 IND; Pfizer’s TIVDAK FDA Approval

Explore More...
chronic-smell-and-flavour-loss-treatment-market-outlook

Chronic Smell and Flavor Loss Treatment Market Garners Attention amid the Pandemic Chaos

ASH Annual Meeting, Major Abstracts, Breakthroughs, Updates, and News

ASH 2022 Annual Meeting – Insights Into Major Diffuse Large B-cell Lymphoma (DLBCL) Abstract and Breakthroughs

Pharma News for Nkarta, Eisai, EQRx, Rigel Pharma, AUM, X4 Pharma

Nkarta’s Anti-CD19 Allogeneic CAR-NK Cell Therapy, NKX019; Eisai Presents Results of lecanemab for Alzheimer’s Disease; EQRx’s Aumolertinib for EGFR-Mutated NSCLC; FDA Approves Olutasidenib for IDH1-Mutated R/R AML; FDA Orphan Drug Designation to AUM302 for Neuroblastoma; X4 Pharma Announces Results for WHIM Syndrome Drug

pd-and-pd-l1-inhibitors-in-cancer-treatment

PD-1 and PD-L1 Inhibitors: Will They Dominate Over Conventional Cancer Therapies?

MedTech News Updates for AnchorDx, UroMems, NeuroLogica, Ypsomed

AnchorDx’s UriFind Bladder Cancer Assay in the US; UroMems Initiates Smart Implant to Treat Stress Urinary Incontinence; FDA 510(k) Clearance to NeuroLogica’s BodyTom 64; CE-IVD Mark Approval to SeekInCure’s Recurrence Monitoring Kit Gets; Ypsomed and CamDiab’s Automated Insulin Dosing System; Boston Scientific to Acquire Apollo Endosurgery

Antibody Drug Conjugates for Cancer Treatment in Asia Healthcare Market

Antibody-Drug Conjugate: The Smart Biological Bomb

Default Blog Image

C4X Discovery and AstraZeneca Signs Deal; FDA Rejects Spectrum’s Poziotinib; Orphan Drug Designation to Tenaya’s Gene Therapy; EC Approves Regeneron’s Libtayo; Response Letter to Poziotinib for Metastatic NSCLC Harboring HER2 Exon 20 Mutations; Japan Approves Trastuzumab Deruxtecan for HER2+ Breast Cancer

Default Blog Image

Nascent Advancements and Emerging Therapies in Chronic Pulmonary Hypertension Treatment Market

EGFR and ALK mutations in the East Asian Lung Cancer Market

ESMO Asia 2022: Role of EGFR and ALK mutations in the East Asian Lung Cancer Market

emerging-rna-interference-drugs

RNA Interference: New Class of Drugs In The Fight Against Disease

gene-therapy-for-complex-diseases

Gene Therapy: The Next Milestone in Treating Complex Diseases

Innovation and Advances in Type 2 Diabetes Treatment and Management

Insights Into the Key Advancements Transforming the Type 2 Diabetes Treatment and Management

emerging-therapies-for-cutaneous-t-cell-lymphoma-treatment

How Will the Emerging Therapies for Cutaneous T-cell Lymphoma Reshuffle its Treatment Landscape

Pharma News for Amgen, AstraZeneca, Sanofi, Anavex, Sensorion, GSK

Amgen’s Olpasiran Candidate; GSK’s Novel Antibiotic for Urinary Tract Infections; AstraZeneca and Sanofi’s Beyfortus Approval; FDA Orphan Designation to Anavex’s Anavex2-73; FDA Rare Pediatric Disease Designation to Sensorion’s OTOF-GT; GSK’s Blenrep Fails in Phase III Trial in R/R Multiple Myeloma

Hemophilia A Market Forecast and Assessment

Roche’s HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape

Pharma News for Actinium, Santhera, Gilead, Seres, BMS, Boehringer

Actinium Announces SIERRA Trial Results; Santhera Seeks FDA Review for Vamorolone; Seres Announces BLA Submission for SER-109; BMS Announces Results of COMMANDS Trial; Boehringer’s PDE4B Moves Late-stage Clinical Testing; FDA Rejects Gilead’s Hepcludex; Approval to J&J’s BCMAxCD3 Bispecific Antibody for Multiple Myeloma; Syncona to Acquire AGTC

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Days
loader